ES2196149T3 - Preparaciones purgantes no acuosas para el colon. - Google Patents

Preparaciones purgantes no acuosas para el colon.

Info

Publication number
ES2196149T3
ES2196149T3 ES96915636T ES96915636T ES2196149T3 ES 2196149 T3 ES2196149 T3 ES 2196149T3 ES 96915636 T ES96915636 T ES 96915636T ES 96915636 T ES96915636 T ES 96915636T ES 2196149 T3 ES2196149 T3 ES 2196149T3
Authority
ES
Spain
Prior art keywords
purgant
watery
colon
formulates
additional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96915636T
Other languages
English (en)
Inventor
Craig A Aronchick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27170740&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2196149(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2196149T3 publication Critical patent/ES2196149T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

SE DESCRIBEN FORMULADOS PURGANTES COLONICOS ADMINISTRADOS POR VIA ORAL Y PROCEDIMIENTOS PARA SU UTILIZACION PARA LLEVAR A CABO LA PURGACION PARCIAL O COMPLETA DEL COLON EN MAMIFEROS, CONSISTIENDO LOS FORMULADOS EN MEZCLAS NO ACUOSAS DE FOSFATO DE SODIO MONOBASICO, DIBASICO Y TRIBASICO, ADMINISTRADOS EN FORMA DE COMPRIMIDOS O CAPSULAS EN CONCENTRACIONES DESDE 0,01 A 0,85 GRAMOS POR KILOGRAMO DE PESO CORPORAL. LAS REALIZACIONES PREFERIDAS INCLUYEN LA ADICION DE LIGANTES, DISPERSANTES Y TAMPONES QUE NO AFECTEN DE FORMA ADVERSA LA OSMOLALIDAD O EFICACIA DE LOS FORMULADOS PURGANTES.
ES96915636T 1996-05-08 1996-05-08 Preparaciones purgantes no acuosas para el colon. Expired - Lifetime ES2196149T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002241445A CA2241445C (en) 1996-05-08 1996-05-08 Non-aqueous colonic purgative formulations
PCT/US1996/006563 WO1997041838A1 (en) 1996-05-08 1996-05-08 Non-aqueous colonic purgative formulations
US08/669,834 US5616346A (en) 1993-05-18 1996-06-26 Non-aqueous colonic purgative formulations

Publications (1)

Publication Number Publication Date
ES2196149T3 true ES2196149T3 (es) 2003-12-16

Family

ID=27170740

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96915636T Expired - Lifetime ES2196149T3 (es) 1996-05-08 1996-05-08 Preparaciones purgantes no acuosas para el colon.

Country Status (8)

Country Link
US (1) US5616346A (es)
EP (1) EP0858326B1 (es)
AT (1) ATE235894T1 (es)
CA (1) CA2241445C (es)
DE (1) DE69627170T2 (es)
DK (1) DK0858326T3 (es)
ES (1) ES2196149T3 (es)
WO (1) WO1997041838A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN634595A0 (en) * 1995-11-03 1995-11-30 Borody, Thomas Julius Improved method for colonic evacuation
US6103268A (en) * 1995-11-03 2000-08-15 Borody; Thomas Julius Administering osmotic colonic evacuant containing a picosulfate
DE69705106T2 (de) * 1996-11-13 2001-09-20 C.B. Fleet Co., Inc. Darmreiniger auf Basis von umhülltem Natriumphosphat
US6162464A (en) * 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
US6447763B1 (en) * 1998-06-12 2002-09-10 Ian L. Gordon Method and system for production and collection of lavage induced stool (LIS) for chemical and biologic tests of cells
US6946149B2 (en) 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
US8361452B2 (en) * 2002-07-15 2013-01-29 Halow George M Bowel cleansing composition
US20160184358A9 (en) * 2002-07-15 2016-06-30 George M. Halow Bowel cleansing composition
US7291324B2 (en) * 2002-10-22 2007-11-06 Braintree Laboratories Inc. Method of bowel cleansing
US6996500B2 (en) * 2002-10-30 2006-02-07 Hewlett-Packard Development Company, L.P. Method for communicating diagnostic data
US7049319B2 (en) * 2003-09-23 2006-05-23 Semaan Abboud Colon cleansing composition and method
US7687075B2 (en) * 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
AU2015221520B2 (en) * 2003-11-19 2017-06-08 Salix Pharmaceuticals, Inc. Colonic purgative composition with soluble binding agent
EP1750702B1 (en) 2004-06-04 2010-08-04 Braintree Laboratories, Inc. Method of bowel cleansing
US20060051428A1 (en) * 2004-09-03 2006-03-09 Nelson Ayala Aspartame and citrate flavored phosphate salt laxative
US20070082061A1 (en) * 2005-10-07 2007-04-12 Nelson Ayala Reduction of saltiness with sweeteners
WO2007079000A2 (en) * 2005-12-29 2007-07-12 Braintree Laboratories, Inc. Kit comprising an osmotic laxative and a stimulant laxative for prepariing the colon for virtual colonoscopy
US7985429B2 (en) 2006-03-03 2011-07-26 C. B. Fleet Company, Inc. Flavored colonic cleansing system
US7998510B2 (en) 2006-08-17 2011-08-16 C. B. Fleet Company, Inc. Low dose colonic cleansing system
USD683210S1 (en) 2007-03-01 2013-05-28 C.B. Fleet Company, Inc. Container for colonic cleansing kit
AU2010239378B2 (en) 2009-04-21 2013-11-21 Dark Canyon Laboratories, Llc Colon lavage system
US8211417B1 (en) 2009-10-31 2012-07-03 Harry Snady Method of bowel cleansing
CN102178694B (zh) * 2011-05-06 2013-03-20 四川健能制药有限公司 磷酸钠盐液体制剂
EP3563838A1 (en) 2013-03-15 2019-11-06 Braintree Laboratories, Inc. Dual use oral pharmaceutical composition tablets of suflate salts and methods of use thereof
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
WO2024256873A1 (en) 2023-06-15 2024-12-19 Sebela Ireland Limited Methods of administering safe colon cleansing compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB917456A (en) * 1958-10-30 1963-02-06 Casco Lab Inc Suppository composition and preparation thereof
US3088870A (en) * 1958-11-25 1963-05-07 Mcdermott Charles Byron Low volume contact laxative enema compositions
US3676553A (en) * 1969-12-15 1972-07-11 Cybersol Therapeutic composition
US3821368A (en) * 1971-06-01 1974-06-28 Cybersal Inc Therapeutic composition
ES8504625A2 (es) * 1972-07-19 1985-05-16 Fisons Iberica S A Mejoras introducidas en el objeto de la patente principal, para: procedimiento para la obtencion de una solucion hipertonica tamponada
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
US4665100A (en) * 1981-03-13 1987-05-12 Eli Lilly And Company Process for formulating a synthetic drug for use in animal feed, and resulting formulation
US4452779A (en) * 1982-02-03 1984-06-05 Cockerill Vernon Composition and method of treating lactating mammals
US4725427A (en) * 1984-03-13 1988-02-16 Albion International, Inc. Effervescent vitamin-mineral granule preparation
US4812311A (en) * 1984-12-21 1989-03-14 The Procter & Gamble Company Kit for use in the treatment of osteoporosis
US4842871A (en) * 1985-08-01 1989-06-27 Pioneer Hi-Bred International, Inc. Method and inoculant for preserving agricultural products for animal feed
US4904474A (en) * 1988-01-25 1990-02-27 Alza Corporation Delivery of drug to colon by oral disage form
GB8812490D0 (en) * 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations
IT1229568B (it) * 1989-04-17 1991-09-04 Giuliani Spa Composizione farmaceutica per uso orale adatta all'impiego nel lavaggio gastro intestinale, in particolare per uso diagnostico, oppure come lassativo catartico.
US5498425A (en) * 1995-03-17 1996-03-12 Block Drug Company, Inc. Phosphosoda buffered saline laxative

Also Published As

Publication number Publication date
DK0858326T3 (da) 2003-07-07
CA2241445C (en) 2001-07-31
EP0858326B1 (en) 2003-04-02
WO1997041838A1 (en) 1997-11-13
EP0858326A1 (en) 1998-08-19
DE69627170T2 (de) 2004-03-04
US5616346A (en) 1997-04-01
EP0858326A4 (en) 1999-09-29
DE69627170D1 (de) 2003-05-08
ATE235894T1 (de) 2003-04-15
CA2241445A1 (en) 1997-11-13

Similar Documents

Publication Publication Date Title
ES2196149T3 (es) Preparaciones purgantes no acuosas para el colon.
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
AR021844A1 (es) Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion
PA8442001A1 (es) Derivados de pirimidina biciclica condensada
ES2161290T3 (es) Derivados de quinazolina.
ES2188783T3 (es) Empleo de una tienotriazolodiazepina para aumentar los niveles de apolipoproteina a-i.
MX9304581A (es) Desoxitaxoles y composiciones farmaceuticas que los contienen
AR066982A2 (es) Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos
ES2185711T3 (es) 1,4-benzotiazepina-1,1-dioxidoshipolipimemicos.
AR029175A1 (es) Derivados 2-amino-fenilpurina, un proceso para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la preparacion de un medicamento
ES2152966T3 (es) Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion.
CO4940450A1 (es) Formulaciones farmaceuticas que contienen voriconazol
EP0594607A4 (en) Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens.
ES2137991T3 (es) Eniantinas y derivados de eniantina para la lucha contra los endoparasitos.
SV1998000029A (es) Compuestos de pirazina ref. pg3186
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
MX9602806A (es) Derivados del 1,2,4-oxadiazol y su uso como parasiticidas para animales.
ES2091689T3 (es) Aplicacion de la carbamazepina y de la oxcarbazepina en el tratamiento de la enfermedad de parkinson y de los sindromes parkinsonianos.
PA8452001A1 (es) Derivados de macrolidos c-4" sustituidos
IL85870A (en) Controlled release pharmaceutical compositions for oral administration containing 3'-azido-3'-deoxythymidine
MX9301197A (es) Derivados de indol.
ES2040394T3 (es) Procedimiento para preparar un material liofilizado de ifosfamida y mesna.
CO5070569A1 (es) Compuesto de aminoazol o una sal farmaceuticamente aceptable del mismo y medicamento que los contienen
ES2055014T3 (es) Productos que contienen psyllium.
ES2153906T3 (es) Uso de incienso para el tratamiento de la enfermedad de alzheimer.